BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 2580625)

  • 1. Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells.
    Cheung NK; Saarinen UM; Neely JE; Landmeier B; Donovan D; Coccia PF
    Cancer Res; 1985 Jun; 45(6):2642-9. PubMed ID: 2580625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface membrane antigen present on neuroblastoma cells but not fetal neuroblasts recognized by a monoclonal antibody (KP-NAC8).
    Matsumura T; Sugimoto T; Sawada T; Amagai T; Negoro S; Kemshead JT
    Cancer Res; 1987 Jun; 47(11):2924-30. PubMed ID: 3567910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
    Woodhouse CS; Morgan AC
    Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors.
    Modak S; Kramer K; Gultekin SH; Guo HF; Cheung NK
    Cancer Res; 2001 May; 61(10):4048-54. PubMed ID: 11358824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly selective recognition of human neuroblastoma cells by mouse monoclonal antibody to a cytoplasmic antigen.
    Gross N; Beck D; Carrel S; Munoz M
    Cancer Res; 1986 Jun; 46(6):2988-94. PubMed ID: 3516388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-neuroblastoma monoclonal antibodies which do not bind to bone marrow cells.
    Frantz CN; Duerst RE; Ryan DH; Gelsomino NL; Constine LS; Gregory PK
    Prog Clin Biol Res; 1985; 175():485-99. PubMed ID: 3887430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human granulocyte surface molecules identified by murine monoclonal antibodies.
    Skubitz KM; Pessano S; Bottero L; Ferrero D; Rovera G; August JT
    J Immunol; 1983 Oct; 131(4):1882-8. PubMed ID: 6619543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18.
    Mujoo K; Kipps TJ; Yang HM; Cheresh DA; Wargalla U; Sander DJ; Reisfeld RA
    Cancer Res; 1989 Jun; 49(11):2857-61. PubMed ID: 2720646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal antibody to tumor-associated ganglioside GD2.
    Katano M; Saxton RE; Irie RF
    J Clin Lab Immunol; 1984 Nov; 15(3):119-26. PubMed ID: 6099419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of tumor antigens and clinical applications of monoclonal antibody (A 2 B 5) for neuroblastoma].
    Etoh T
    Gan No Rinsho; 1985 Mar; 31(3):299-302. PubMed ID: 3889400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody recognizing a human neuroblastoma-associated antigen.
    Smith RG; Reynolds CP
    Diagn Clin Immunol; 1987; 5(4):209-20. PubMed ID: 3322607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens.
    Young DA; Prout GR; Lin CW
    Cancer Res; 1985 Sep; 45(9):4439-46. PubMed ID: 3896480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of human small cell lung cancer differentiation antigens using a panel of rat monoclonal antibodies.
    Rosen ST; Mulshine JL; Cuttitta F; Fedorko J; Carney DN; Gazdar AF; Minna JD
    Cancer Res; 1984 May; 44(5):2052-61. PubMed ID: 6713399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
    Tong AW; Lee J; Stone MJ
    Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monoclonal antibodies directed against melanoma tumor-associated antigens.
    Kan-Mitchell J; Imam A; Kempf RA; Taylor CR; Mitchell MS
    Cancer Res; 1986 May; 46(5):2490-6. PubMed ID: 3697990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of cell surface membrane antigens in a common acute lymphoblastic leukemia-associated antigen-expressing neuroblastoma cell line (SJ-N-CG) with morphological differentiation.
    Sugimoto T; Sawada T; Negoro S; Kidowaki T; Morioka H; Matsumura T; Kemshead JT; Seeger RC
    Cancer Res; 1985 Jan; 45(1):358-64. PubMed ID: 2981159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies against SSEA-1 antigen: binding properties and inhibition of human natural killer cell activity against target cells bearing SSEA-1 antigen.
    Harris JF; Chin J; Jewett MA; Kennedy M; Gorczynski RM
    J Immunol; 1984 May; 132(5):2502-9. PubMed ID: 6143780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated glycolipid antigens defined by monoclonal antibodies.
    Hakomori S
    Bull Cancer; 1983; 70(2):118-26. PubMed ID: 6191806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement depletion in vitro limits monoclonal antibody 6-19-dependent complement-mediated killing of tumor cells in bone marrow.
    Duerst RE; Rose D; Frantz CN
    Exp Hematol; 1991 Oct; 19(9):863-7. PubMed ID: 1893961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.